Skip to main content
Top

11-03-2024 | Osteosarcoma | Case Report

Low-grade central osteosarcoma with extraosseous dedifferentiation: a rare case

Authors: Kengo Kawaguchi, Kenichi Kohashi, Koji Sagiyama, Mikiko Hashisako, Akira Nabeshima, Nokitaka Setsu, Makoto Endo, Takeshi Iwasaki, Yasuharu Nakashima, Yoshinao Oda

Published in: Skeletal Radiology

Login to get access

Abstract

Low-grade central osteosarcoma (LGCOS), which arises from the intramedullary cavity of the metaphysis of long bones, occasionally exhibits extraosseous spread. Approximately 10–30% of patients with LGCOS exhibit dedifferentiation, but it is rare to experience a primary tumor with a dedifferentiated component. A 38-year-old female patient presented with right knee pain for two months. Imaging studies revealed a bone mass with extraosseous involvement. Wide resection was performed, and pathologic examination led to the diagnosis of LGCOS with a dedifferentiated extraosseous lesion. A single defect in the bone cortex constituted the boundary between the low- and high-grade components. The extraosseous high-grade component included more tumor cells with p53 overexpression and more murine double minute 2 (MDM2) copies compared with the low-grade component. These genetic mutations and copy number alterations can be associated with malignant transformation of LGCOS.
Literature
1.
go back to reference WHO Classification of Tumours Editorial Board. Soft tissue and bone tumours 5th ed. IARC Press. 2020. WHO Classification of Tumours Editorial Board. Soft tissue and bone tumours 5th ed. IARC Press. 2020.
3.
go back to reference Choong PF, Pritchard DJ, Rock MG, Sim FH, McLeod RA, Unni KK. Low grade central osteogenic sarcoma. A long-term followup of 20 patients. Clin Orthop Relat Res. 1996(322):198–206. Choong PF, Pritchard DJ, Rock MG, Sim FH, McLeod RA, Unni KK. Low grade central osteogenic sarcoma. A long-term followup of 20 patients. Clin Orthop Relat Res. 1996(322):198–206.
4.
go back to reference Kenan S, Ginat DT, Steiner GC. Dedifferentiated high-grade osteosarcoma originating from low-grade central osteosarcoma of the fibula. Skeletal Radiol. 2007;36(4):347–51.CrossRefPubMed Kenan S, Ginat DT, Steiner GC. Dedifferentiated high-grade osteosarcoma originating from low-grade central osteosarcoma of the fibula. Skeletal Radiol. 2007;36(4):347–51.CrossRefPubMed
5.
go back to reference Iemoto Y, Ushigome S, Fukunaga M, Nikaido T, Asanuma K. Case report 679. Central low-grade osteosarcoma with foci of dedifferentiation. Skeletal Radiol. 1991; 20(5):379–382. Iemoto Y, Ushigome S, Fukunaga M, Nikaido T, Asanuma K. Case report 679. Central low-grade osteosarcoma with foci of dedifferentiation. Skeletal Radiol. 1991; 20(5):379–382.
6.
go back to reference Ogose A, Hotta T, Emura I, Imaizumi S, Takeda M, Yamamura S. Repeated dedifferentiation of low-grade intraosseous osteosarcoma. Hum Pathol. 2000;31(5):615–8.CrossRefPubMed Ogose A, Hotta T, Emura I, Imaizumi S, Takeda M, Yamamura S. Repeated dedifferentiation of low-grade intraosseous osteosarcoma. Hum Pathol. 2000;31(5):615–8.CrossRefPubMed
7.
go back to reference Dujardin F, Binh MB, Bouvier C, et al. MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone. Mod Pathol. 2011;24(5):624–37.CrossRefPubMed Dujardin F, Binh MB, Bouvier C, et al. MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone. Mod Pathol. 2011;24(5):624–37.CrossRefPubMed
8.
go back to reference Duhamel LA, Ye H, Halai D, et al. Frequency of Mouse Double Minute 2 (MDM2) and Mouse Double Minute 4 (MDM4) amplification in parosteal and conventional osteosarcoma subtypes. Histopathology. 2012;60(2):357–9.CrossRefPubMed Duhamel LA, Ye H, Halai D, et al. Frequency of Mouse Double Minute 2 (MDM2) and Mouse Double Minute 4 (MDM4) amplification in parosteal and conventional osteosarcoma subtypes. Histopathology. 2012;60(2):357–9.CrossRefPubMed
9.
go back to reference Adachi T, Oda Y, Sakamoto A, et al. Immunoreactivity of p53, mdm2, and p21WAF1 in dedifferentiated liposarcoma: special emphasis on the distinct immunophenotype of the well-differentiated component. Int J Surg Pathol. 2001;9(2):99–109.CrossRefPubMed Adachi T, Oda Y, Sakamoto A, et al. Immunoreactivity of p53, mdm2, and p21WAF1 in dedifferentiated liposarcoma: special emphasis on the distinct immunophenotype of the well-differentiated component. Int J Surg Pathol. 2001;9(2):99–109.CrossRefPubMed
10.
go back to reference Yamashita K, Kohashi K, Yamada Y, et al. Prognostic significance of the MDM2/HMGA2 ratio and histological tumor grade in dedifferentiated liposarcoma. Genes Chromosomes Cancer. 2021;60(1):26–37.CrossRefPubMed Yamashita K, Kohashi K, Yamada Y, et al. Prognostic significance of the MDM2/HMGA2 ratio and histological tumor grade in dedifferentiated liposarcoma. Genes Chromosomes Cancer. 2021;60(1):26–37.CrossRefPubMed
Metadata
Title
Low-grade central osteosarcoma with extraosseous dedifferentiation: a rare case
Authors
Kengo Kawaguchi
Kenichi Kohashi
Koji Sagiyama
Mikiko Hashisako
Akira Nabeshima
Nokitaka Setsu
Makoto Endo
Takeshi Iwasaki
Yasuharu Nakashima
Yoshinao Oda
Publication date
11-03-2024
Publisher
Springer Berlin Heidelberg
Published in
Skeletal Radiology
Print ISSN: 0364-2348
Electronic ISSN: 1432-2161
DOI
https://doi.org/10.1007/s00256-024-04647-x